Reassessing the measurement and presence of therapeutic misconception in a phase 1 setting.
Eli R AbernethyGavin P CampbellRachel S HianikMary Catherine ThomsonShannon M BleeHannah Claire SiboldMargie D DixonJeffrey M SwitchenkoRebecca D PentzPublished in: Cancer (2021)
Therapeutic misconception (TM) refers to research subjects' failure to distinguish the goals of clinical research from standard personal care. TM signals a basic misunderstanding of the purpose of clinical research, threatening valid informed consent to participate in clinical trials. TM has traditionally been determined by questioning patients about their research study's purpose. Recent research, however, has questioned whether TM is as prevalent due to discrepancies between patient/researcher interpretations of TM questions. By developing an interview-tool receptive to these advancements, we report a lower TM estimate in the phase 1 setting (12%) than we found previously in a similar cohort (68%).